TransCode Therapeutics

$0.00 (0.00%) Today
$0.00 (0.00%) As of 4:00 AM UTC after-hours

Why Robinhood?

You can buy or sell RNAZ and other stocks, options, and ETFs commission-free!

About RNAZ

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

CEO
Robert Michael Dudley
Employees
6
Headquarters
Boston, Massachusetts
Founded
2016

RNAZ Key Statistics

Market Cap
47.83M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
—
High Today
—
Low Today
—
Open Price
—
Volume
0.00
52 Week High
$4.00
52 Week Low
$4.00
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure